Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 23, n. 1, 2022. DOI: 10.7175/fe.v23i1.1510. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1510. Acesso em: 29 oct. 2025.